Found 18 results
Filters: Author is J.L. Wang  [Clear All Filters]
Y. S. Wang, Liu, L., Xu, X. Y., Wang, J. L., Zhou, H., Li, T. L., and Liang, Z. A., Association of interleukin-1β -511C/T promoter polymorphism with COPD risk: a meta-analysis, vol. 14, pp. 4477-4484, 2015.
X. Q. Qu, Wang, W. J., Tang, S. S., Liu, Y., and Wang, J. L., Correlation between interleukin-6 expression in articular cartilage bone and osteoarthritis, vol. 14, pp. 14189-14195, 2015.
J. L. Wang, Zhang, N. Z., Huang, S. Y., Xu, Y., Wang, R. A., and Zhu, X. Q., Low-level sequence variation in Toxoplasma gondii calcium-dependent protein kinases among different genotypes, vol. 14, pp. 4949-4956, 2015.
M. J. Ma, Liu, H. C., Qu, X. Q., and Wang, J. L., Matrix metalloproteinase-3 gene polymorphism and its mRNA expression in rheumatoid arthritis, vol. 14, pp. 15652-15659, 2015.
J. L. Wang, Liu, H. J., Li, F., Yang, W. Y., Wang, J. M., Tan, S. F., and Wang, Q., Multidrug resistance gene (MDR1) polymorphisms may not be directly associated with response to imatinib in chronic myeloid leukemia, vol. 14, pp. 14967-14978, 2015.
C. G. Mei, Gui, L. S., Fu, C. Z., Wang, H. C., Wang, J. L., Cheng, G., and Zan, L. S., Polymorphisms in the bovine CIDEC gene are associated with body measurement traits and meat quality traits in Qinchuan cattle, vol. 14, pp. 9013-9023, 2015.
H. G. Wang, Yang, J., Han, H., Xu, F., Bian, Y., Zhang, H., and Wang, J. L., TNF-αG-308A polymorphism is associated with insulin resistance: a meta-analysis, vol. 14, pp. 563-573, 2015.
J. L. Wang, Li, S. Y., Luo, Y. F., Zhai, Y. P., and Wei, X. Q., Changes of Th1/Th2 cytokines in immunocompetent patients with pulmonary cryptococcosis, vol. 12, pp. 5733-5742, 2013.
C. Z. Fu, Wang, H., Mei, C. G., Wang, J. L., Jiang, B. J., Ma, X. H., Wang, H. B., Cheng, G., and Zan, L. S., SNPs at 3'-UTR of the bovine CDIPT gene associated with Qinchuan cattle meat quality traits, vol. 12, pp. 775-782, 2013.
Antonsson BE (1994). Purification and characterization of phosphatidylinositol synthase from human placenta. Biochem. J. 297 (Pt 3): 517-522. PMid:8110188 PMCid:1137864   Brethour JR (1994). Estimating marbling score in live cattle from ultrasound images using pattern recognition and neural network procedures. J. Anim. Sci. 72: 1425-1432. PMid:8071165   Chakraborty R, Zhong Y, de AM, Clemens PR, et al. (1994). Linkage disequilibria among (CA)n polymorphisms in the human dystrophin gene and their implications in carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophies. Genomics 21: 567-570. PMid:7959733   Chen H and Leibenguth F (1995). Studies on multilocus fingerprints, RAPD markers, and mitochondrial DNA of a gynogenetic fish (Carassius auratus gibelio). Biochem. Genet. 33: 297-306. PMid:8748455   Deguchi A, Segawa K, Hosaka K, Weinstein IB, et al. (2002). Overexpression of phosphatidylinositol synthase enhances growth and G1 progression in NIH3T3 cells. Jpn. J. Cancer Res. 93: 157-166. PMid:11856479   Fu YY, Xiong YZ, Pan G, Cheng L, et al. (2009). Association of the polymorphism of porcine CDIPT gene with carcass and meat quality traits. Chin. J. Anim. Vet. Sci. 40: 787-791.   Hamlin KE, Green RD, Perkins TL, Cundiff LV, et al. (1995). Real-time ultrasonic measurement of fat thickness and longissimus muscle area: I. Description of age and weight effects. J. Anim. Sci. 73: 1713-1724. PMid:7673065   Lykidis A, Jackson PD, Rock CO and Jackowski S (1997). The role of CDP-diacylglycerol synthetase and phosphatidylinositol synthase activity levels in the regulation of cellular phosphatidylinositol content. J. Biol. Chem. 272: 33402-33409. PMid:9407135   Nei M and Roychoudhury AK (1974). Sampling variances of heterozygosity and genetic distance. Genetics 76: 379-390. PMid:4822472 PMCid:1213072   Nei M and Li WH (1979). Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc. Natl. Acad. Sci. U. S. A. 76: 5269-5273. PMid:291943 PMCid:413122   Neilson JR and Sandberg R (2010). Heterogeneity in mammalian RNA 3' end formation. Exp. Cell Res. 316: 1357-1364. PMid:20211174 PMCid:2866830   White DA (1973). The Phospholipid Composition of Mammalian Tissues. In: Form and Function of Phospholipids (Ansell GB, Hawthorne JN and Dawson RMC, eds.). Elsevier, Amsterdam, 441-482.   Zhao J, Hyman L and Moore C (1999). Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol. Mol. Biol. Rev. 63: 405-445. PMid:10357856 PMCid:98971   Zhou JP, Zhu XP, Zhang W, Qin F, et al. (2011). A novel single-nucleotide polymorphism in the 5' upstream region of the prolactin receptor gene is associated with fiber traits in Liaoning cashmere goats. Genet. Mol. Res. 10: 2511-2516. PMid:22009863   Zimin AV, Delcher AL, Florea L, Kelley DR, et al. (2009). A whole-genome assembly of the domestic cow, Bos taurus. Genome Biol. 10: R42. PMid:19393038 PMCid:2688933
Y. Z. Li, Wang, L. J., Li, X., Li, S. L., Wang, J. L., Wu, Z. H., Gong, L., and Zhang, X. D., Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies, vol. 12, pp. 1035-1044, 2013.
Altinkaya SO, Ugur M, Ceylaner G, Ozat M, et al. (2011). Vascular endothelial growth factor +405 C/G polymorphism is highly associated with an increased risk of endometriosis in Turkish women. Arch. Gynecol. Obstet. 283: 267-272. PMid:20041256   Attar R, Agachan B, Kuran SB, Toptas B, et al. (2010). Genetic variants of vascular endothelial growth factor and risk for the development of endometriosis. In Vivo 24: 297-301. PMid:20555002   Bhanoori M, Arvind BK, Pavankumar Reddy NG, Lakshmi RK, et al. (2005). The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum. Reprod. 20: 1844-1849. PMid:15746194   Cosin R, Gilabert-Estelles J, Ramon LA, Espana F, et al. (2009). Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression. Fertil. Steril. 92: 1214-1220. PMid:18930211   Ferrara N (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25: 581-611. PMid:15294883   Ferrara N, Gerber HP and LeCouter J (2003). The biology of VEGF and its receptors. Nat. Med. 9: 669-676. PMid:12778165   Fukumura D, Xavier R, Sugiura T, Chen Y, et al. (1998). Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715-725.   Gentilini D, Somigliana E, Vigano P, Vignali M, et al. (2008). The vascular endothelial growth factor +405G>C polymorphism in endometriosis. Hum. Reprod. 23: 211-215. PMid:17977866   Girling JE and Rogers PA (2005). Recent advances in endometrial angiogenesis research. Angiogenesis 8: 89-99. PMid:16211359   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. PMid:12111919   Hsieh YY, Chang CC, Tsai FJ, Yeh LS, et al. (2004). T allele for VEGF gene-460 polymorphism at the 5'-untranslated region: association with a higher susceptibility to endometriosis. J. Reprod. Med. 49: 468-472. PMid:15283056   Ikuhashi Y, Yoshida S, Kennedy S, Zondervan K, et al. (2007). Vascular endothelial growth factor +936 C/T polymorphism is associated with an increased risk of endometriosis in a Japanese population. Acta Obstet. Gynecol. Scand. 86: 1352-1358. PMid:17963063   Kang S, Zhao J, Liu Q, Zhou R, et al. (2009). Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. Environ. Mol. Mutagen. 50: 361-366. PMid:19197986   Kim JG, Kim JY, Jee BC, Suh CS, et al. (2008). Association between endometriosis and polymorphisms in endostatin and vascular endothelial growth factor and their serum levels in Korean women. Fertil. Steril. 89: 243-245. PMid:17482599   Kim SH, Choi YM, Choung SH, Jun JK, et al. (2005). Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum. Reprod. 20: 2904-2908. PMid:15979997   Lamp M, Saare M, Laisk T, Karro H, et al. (2010). Genetic variations in vascular endothelial growth factor but not in angiotensin I-converting enzyme genes are associated with endometriosis in Estonian women. Eur. J. Obstet. Gynecol. Reprod. Biol. 153: 85-89. PMid:20685027   Liu Q, Li Y, Zhao J, Sun DL, et al. (2009a). Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women. Hum. Reprod. 24: 2660-2666. PMid:19531502   Liu Q, Li Y, Zhao J, Zhou RM, et al. (2009b). Association of single nucleotide polymorphisms in VEGF gene with the risk of endometriosis and adenomyosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 26: 165-169. PMid:19350508   Matalliotakis IM, Katsikis IK and Panidis DK (2005). Adenomyosis: what is the impact on fertility? Curr. Opin. Obstet. Gynecol. 17: 261-264. PMid:15870560   Missmer SA and Cramer DW (2003). The epidemiology of endometriosis. Obstet. Gynecol. Clin. North Am. 30: 1-19, vii.   Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680. PMid:16467236   Signorile PG and Baldi A (2010). Endometriosis: new concepts in the pathogenesis. Int. J. Biochem. Cell Biol. 42: 778-780. PMid:20230903   Varma R, Rollason T, Gupta JK and Maher ER (2004). Endometriosis and the neoplastic process. Reproduction 127: 293-304. PMid:15016949   Vigano P, Parazzini F, Somigliana E and Vercellini P (2004). Endometriosis: epidemiology and aetiological factors. Best. Pract. Res. Clin. Obstet. Gynaecol. 18: 177-200. PMid:15157637   von Elm E, Altman DG, Egger M, Pocock SJ, et al. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370: 1453-1457.   Watson CJ, Webb NJ, Bottomley MJ and Brenchley PE (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232- 1235. PMid:10930302   Zhang L, Liu JL, Zhang YJ and Wang H (2011). Association between HLA-B*27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin. Exp. Rheumatol 29: 285-292. PMid:21418777   Zhao ZZ, Nyholt DR, Thomas S, Treloar SA, et al. (2008). Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. Mol. Hum. Reprod. 14: 531-538. PMid:18650217   Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. PMid:15593093
H. G. Wang, Wang, J. L., Chang, P., Cao, F. L., Liu, X. C., Ma, Y. B., Zhai, G. X., and Gao, H. Q., Endothelial nitric oxide synthase gene polymorphisms and essential hypertension in Han Chinese, vol. 9, pp. 1896-1907, 2010.
Casas JP, Bautista LE, Humphries SE and Hingorani AD (2004). Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109: 1359-1365. PMid:15007011   Casas JP, Cavalleri GL, Bautista LE, Smeeth L, et al. (2006). Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 164: 921-935. PMid:17018701   Dosh SA (2002). The treatment of adults with essential hypertension. J. Fam. Pract. 51: 74-80. PMid:11927069   Forte P, Copland M, Smith LM, Milne E, et al. (1997). Basal nitric oxide synthesis in essential hypertension. Lancet 349: 837-842.   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. PMid:12111919   Huang HB, Lin LX and Chen MQ (2002). Association of polymorphism of endothelial nitric oxide synthase gene with essential hypertension and type 2 diabetes mellitus. Chin. J. Endocrinol. Metab. 18: 16-19.   Huang PL, Huang Z, Mashimo H, Bloch KD, et al. (1995). Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242. PMid:7545787   Li DB, Hua Q, Pi L, Zou HQ, et al. (2003). Association of polymorphism of endothelial nitric oxide synthase gene with essential hypertension. Chin. J. Hypertens. 11: 552-554.   Li DB, Hua Q and Pi L (2004). Association of G894T polymorphism of endothelial nitric oxide synthase gene and essential hypertension. Chin. J. Hypertens. 12: 326-330.   Li DB, Hua Q and Pi L (2006). The relationship of T786C polymorphism of endothelial nitric oxide synthase gene to essential hypertension. J. Cap. Univ. Med. Sci. 27: 226-229.   Li DJ, Wu WF, Xu L, Jiang XB, et al. (2009). Effect of G894T mutation in the endothelial nitric oxide synthase gene and abnormality of waist-to-hip ratio on essential hypertension. Chin. Gen. Pract. 12: 1173-1175, 1178.   Liang Q, Yang XY, Yang G and Cui JH (2006). Association of angiotensinogen and endothelial nitric oxide synthase gene polymorphism with essential hypertension. J. Youjiang Med. Col. Nationalities 28: 341-343.   Liu HZ and Ha DW (2002). Relationship between 894G→T polymorphism of endothelial nitric oxide synthase gene and essential hypertension. J. Chin. Circ. 17: 42-44.   Ma HX, Xie ZX, Niu YH, Li ZY, et al. (2006). Single nucleotide polymorphisms in NOS3 A-922G, T-786C and G894T: a correlation study of the distribution of their allelic combinations with hypertension in Chinese Han population. Yi. Chuan 28: 3-10. PMid:16469708   Macaskill P, Walter SD and Irwig L (2001). A comparison of methods to detect publication bias in meta-analysis. Stat. Med. 20: 641-654. PMid:11223905   Mayer B and Hemmens B (1997). Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22: 477-481.   Miyahara K, Kawamoto T, Sase K, Yui Y, et al. (1994). Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur. J. Biochem. 223: 719-726. PMid:7519987   Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, et al. (1998). Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32: 3-8. PMid:9674630   Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, et al. (2008). Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radic. Biol. Med. 44: 1912-1918. PMid:18325347   Newhouse SJ, Wallace C, Dobson R, Mein C, et al. (2005). Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British genetics of hypertension study. Hum. Mol. Genet. 14: 1805-1814. PMid:15888480   Niu WQ, Qi Y, Zhang LT, Qi YX, et al. (2009). Endothelial nitric oxide synthase genetic variation and essential hypertension risk in Han Chinese: the Fangshan study. J. Hum. Hypertens. 23: 136-139. PMid:18769442   Pereira TV, Rudnicki M, Cheung BM, Baum L, et al. (2007). Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J. Hypertens. 25: 1763-1774. PMid:17762636   Schmidt HH and Walter U (1994). NO at work. Cell 78: 919-925.   Tan JC, Zhu ZM, Zhu SJ, Yu CQ, et al. (2003). The GNB3 and eNOS gene polymorphisms in patients with essential hypertension. Chin. J. Cardiol. 31: 16-19.   Tang JL (2005). Selection bias in meta-analyses of gene-disease associations. PLoS. Med. 2: e409. PMid:16363911 PMCid:1285067   Thaha M, Pranawa, Yogiantoro M, Sutjipto, et al. (2008). Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin. Nephrol. 70: 144-154. PMid:18793530   Thomas GD, Zhang W and Victor RG (2001). Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension. JAMA 285: 2055-2057. PMid:11311074   Tobias A (1999). Assessing the influence of a single study in the meta-analysis estimate. Stata Tech. Bull. 8: 15-17.   Trikalinos TA, Salanti G, Khoury MJ and Ioannidis JP (2006). Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am. J. Epidemiol. 163: 300-309. PMid:16410351   Tsukada T, Yokoyama K, Arai T, Takemoto F, et al. (1998). Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245: 190-193. PMid:9535806   Wu XF and Huang QY (2009). The a/b polymorphism in the eNOS gene is associated with essential hypertension but not type 2 diabetes in hubei Han Chinese. Prog. Mod. Biomed. 9: 69-72.   Yuan H, Li QX, Ping YH and Liu GZ (2007). Polymorphisms of endothelial nitric oxide synthase NOS3 4a/b and HindIII restriction site of the Y-chromosome in essential hypertension. Chin. J. Lab. Med. 30: 392-394.   Zhao Q, Su SY, Chen SF, Li B, et al. (2006). Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin Med. J. 119: 1065-1071.   Zhao XY, Guo X, Qiu CC, Zhang DH, et al. (2005). Relationship of endothelial nitric oxide synthase gene polymorphism, the 27-bp repeat in intron 4 with essential hypertension of the northern Han nationality in China. Chin. J. Rehabil. Theory Pract. 11: 422-424.   Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. PMid:15593093   Zintzaras E and Lau J (2008). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J. Clin. Epidemiol. 61: 634-645. PMid:18538260   Zintzaras E, Kitsios G and Stefanidis I (2006). Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48: 700-710. PMid:16940230